Dr. Simon Francis Thomsen gave an overview of HS pathogenesis; current and emerging biologics for HS, which include TNF and IL17 monoclonal antibodies; and collagen-derived biomarkers in the serum as predictors of HS disease stage. This evidence concerns the gene IL17A and histiocytic sarcoma.